NZ710246A - Methods of treating cardiovasular indications - Google Patents
Methods of treating cardiovasular indicationsInfo
- Publication number
- NZ710246A NZ710246A NZ710246A NZ71024614A NZ710246A NZ 710246 A NZ710246 A NZ 710246A NZ 710246 A NZ710246 A NZ 710246A NZ 71024614 A NZ71024614 A NZ 71024614A NZ 710246 A NZ710246 A NZ 710246A
- Authority
- NZ
- New Zealand
- Prior art keywords
- treating
- cardiovasular
- indications
- methods
- patient
- Prior art date
Links
- 108020001621 Natriuretic Peptide Proteins 0.000 abstract 1
- 102000004571 Natriuretic peptide Human genes 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 239000000692 natriuretic peptide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2221—Relaxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361756692P | 2013-01-25 | 2013-01-25 | |
| PCT/IB2014/000253 WO2014115033A2 (en) | 2013-01-25 | 2014-01-24 | Methods of treating cardiovascular indications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ710246A true NZ710246A (en) | 2016-11-25 |
Family
ID=50382492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ710246A NZ710246A (en) | 2013-01-25 | 2014-01-24 | Methods of treating cardiovasular indications |
Country Status (19)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015184248A1 (en) * | 2014-05-30 | 2015-12-03 | Concert Pharmaceuticals, Inc. | Methods of treating fibrotic diseases |
| CN105617360B (zh) * | 2015-12-04 | 2018-12-21 | 中国农业大学 | C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用 |
| US20180193270A1 (en) | 2016-11-29 | 2018-07-12 | PureTech Health LLC | Exosomes for delivery of therapeutic agents |
| CN110278941B (zh) * | 2019-07-11 | 2021-05-28 | 西安国际医学中心有限公司 | 一种含有钠尿肽的离体心脏保护液 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3346953A1 (de) | 1983-12-24 | 1985-08-14 | Organogen Medizinisch-Molekularbiologische Forschungsgesellschaft mbH, 6900 Heidelberg | Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung |
| US5449751A (en) | 1987-03-02 | 1995-09-12 | Pharma Bissendorf Peptide Gmbh | Cardiodilatin fragment, process for preparing same and use thereof |
| US5461142A (en) | 1987-11-07 | 1995-10-24 | Pharma Bissendorf Peptide Gmbh | Phosphorylated derivatives of cardiodilatin/ANF peptides |
| US5166191A (en) * | 1991-08-19 | 1992-11-24 | Genentech, Inc. | Use of relaxin in cardiovascular therapy |
| DE4216133A1 (de) | 1992-05-15 | 1993-11-18 | Bissendorf Peptide Gmbh | Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen |
| WO1995033769A1 (de) | 1994-06-02 | 1995-12-14 | Boehringer Mannheim Gmbh | Verfahren zur herstellung von cardiodilatin-fragmenten, hochgereinigte cardiodilatin-fragmente und zwischenprodukte zu deren herstellung |
| DE19951471A1 (de) | 1999-10-26 | 2001-05-03 | Forssmann Wolf Georg | Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen |
| US6407211B1 (en) * | 1999-12-17 | 2002-06-18 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides |
| JP2004510743A (ja) * | 2000-10-04 | 2004-04-08 | モレキュラー メディシン リサーチ インスティチュート | レラキシンのアゴニストまたはアンタゴニストの投与によるアポトーシスを調節する方法 |
| KR101271635B1 (ko) * | 2001-12-21 | 2013-06-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 알부민 융합 단백질 |
| US20050113286A1 (en) * | 2002-03-18 | 2005-05-26 | Schreiner George F. | Methods for treating congestive heart failure |
| US7732406B2 (en) * | 2005-04-07 | 2010-06-08 | Cardiopep Pharma Gmbh | Use of natriuretic peptide for treating heart failure |
| WO2009034134A2 (en) * | 2007-09-11 | 2009-03-19 | Pharis Biotec Gmbh | Use of natriuretic peptides for treating angioedema syndromes |
| WO2009086126A2 (en) * | 2007-12-21 | 2009-07-09 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides |
| AU2009246112B2 (en) * | 2008-05-16 | 2013-05-02 | Corthera, Inc. | Method of treating chronic heart failure |
| US8642550B2 (en) * | 2008-10-24 | 2014-02-04 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides without hypotensive inducing capability |
| JP2010116325A (ja) * | 2008-11-11 | 2010-05-27 | Institute For Protein Science Co Ltd | Ｓｉｒｓ患者を救命するためのペプチド組成物 |
| US20110014180A1 (en) * | 2009-07-16 | 2011-01-20 | Masafumi Koide | Preparations for tissue restoration containing atrial diuretic hormone and family molecules as active ingredients; method of restoring tissue using the preparation; agents for growing, restoring, promoting growth of hair and agents for promoting restoration of skin tissue and cardiac muscle tissue containing atrial diuretic hormone family molecules as active ingredients; method of growing, restoring, promoting growth of hair by using the agents; and method of promoting restoration of skin tissue and cardiac muscle tissue |
| PH12012500562A1 (en) * | 2009-09-25 | 2012-10-22 | Takeda Pharmaceuticals Co | Novel npr-b antagonists |
| US8551938B2 (en) * | 2009-09-25 | 2013-10-08 | Alcon Research, Ltd. | NPR-B agonists |
| EP2547356A1 (en) * | 2010-03-15 | 2013-01-23 | Wolf-Georg Forssmann | Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes while avoiding a rebound |
| EP2605797A2 (en) * | 2010-08-20 | 2013-06-26 | Cerulean Pharma Inc. | Therapeutic peptide-polymer conjugates, particles, compositions, and related methods |
-
2014
- 2014-01-24 NZ NZ710246A patent/NZ710246A/en not_active IP Right Cessation
- 2014-01-24 CA CA2898571A patent/CA2898571A1/en not_active Abandoned
- 2014-01-24 SG SG11201505492XA patent/SG11201505492XA/en unknown
- 2014-01-24 JP JP2015554265A patent/JP2016505065A/ja active Pending
- 2014-01-24 BR BR112015017432A patent/BR112015017432A2/pt not_active IP Right Cessation
- 2014-01-24 US US14/163,273 patent/US20140213520A1/en not_active Abandoned
- 2014-01-24 AU AU2014208851A patent/AU2014208851B2/en not_active Ceased
- 2014-01-24 AP AP2015008624A patent/AP2015008624A0/xx unknown
- 2014-01-24 MX MX2015009606A patent/MX2015009606A/es unknown
- 2014-01-24 KR KR1020157022509A patent/KR20150108903A/ko not_active Withdrawn
- 2014-01-24 TW TW103102790A patent/TW201442722A/zh unknown
- 2014-01-24 CN CN201480013163.1A patent/CN105025918A/zh active Pending
- 2014-01-24 US US14/163,130 patent/US20140213519A1/en not_active Abandoned
- 2014-01-24 WO PCT/IB2014/000253 patent/WO2014115033A2/en not_active Ceased
- 2014-01-24 EP EP14712761.7A patent/EP2948165A2/en not_active Withdrawn
- 2014-01-24 EA EA201500765A patent/EA201500765A1/ru unknown
-
2015
- 2015-07-13 PH PH12015501559A patent/PH12015501559A1/en unknown
- 2015-07-13 IL IL239909A patent/IL239909A0/en unknown
- 2015-07-23 TN TN2015000315A patent/TN2015000315A1/en unknown
- 2015-07-24 DO DO2015000175A patent/DOP2015000175A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201500765A1 (ru) | 2015-12-30 |
| WO2014115033A3 (en) | 2015-02-26 |
| AP2015008624A0 (en) | 2015-07-31 |
| DOP2015000175A (es) | 2015-11-15 |
| CN105025918A (zh) | 2015-11-04 |
| MX2015009606A (es) | 2016-04-26 |
| TN2015000315A1 (en) | 2017-01-03 |
| US20140213519A1 (en) | 2014-07-31 |
| SG11201505492XA (en) | 2015-08-28 |
| CA2898571A1 (en) | 2014-07-31 |
| PH12015501559A1 (en) | 2015-09-21 |
| US20140213520A1 (en) | 2014-07-31 |
| JP2016505065A (ja) | 2016-02-18 |
| KR20150108903A (ko) | 2015-09-30 |
| AU2014208851B2 (en) | 2016-12-22 |
| WO2014115033A2 (en) | 2014-07-31 |
| BR112015017432A2 (pt) | 2017-07-11 |
| AU2014208851A1 (en) | 2015-08-06 |
| TW201442722A (zh) | 2014-11-16 |
| IL239909A0 (en) | 2015-08-31 |
| EP2948165A2 (en) | 2015-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU345053S (en) | Syringe | |
| AU344214S (en) | Analysis system | |
| NZ627078A (en) | Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy | |
| AU346291S (en) | Medical dressing | |
| IN2014MN01970A (cg-RX-API-DMAC10.html) | ||
| AU342788S (en) | Patient interface assembly | |
| ZA201500336B (en) | Human antibodies to gfr¿3 and methods of use thereof | |
| AU342787S (en) | Patient interface assembly | |
| IN2014DN07247A (cg-RX-API-DMAC10.html) | ||
| MX349544B (es) | Extractos de maesa japonica y métodos de uso. | |
| AU342733S (en) | Rail connector | |
| MX362861B (es) | Metodos y composiciones para tratar esclerosis multiple y trastornos relacionadods. | |
| ZA201601967B (en) | Novel peptides and analogs for use in the treatment of oral mucositis | |
| AU343718S (en) | Sticking plaster used for medical purposes | |
| TN2015000315A1 (en) | Methods of treating cardiovascular indications | |
| AU343717S (en) | Sticking plaster used for medical purposes | |
| MX2015012580A (es) | El uso de sdf-1 para atenuar la formacion de cicatrices. | |
| EP4385563A3 (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine | |
| CR20130208A (es) | Unidad de interfaz, sistema de medicion y un metodo en una unidad de interfaz | |
| AU352446S (en) | Elbow connector for a patient interface assembly | |
| IN2014MN01871A (cg-RX-API-DMAC10.html) | ||
| UA114965C2 (uk) | Композиція та спосіб для покращення мобілізаційних резервів організму | |
| UA59766U (ru) | Способ медицинской реабилитации взрослых больных с посттравматическими стрессовыми расстройствами | |
| UA59230U (ru) | Способ определения индивидуальной магнитной чувствительности организма человека | |
| UA103263C2 (ru) | Способ увеличения полового члена и электромеханический экстендер для его реализации |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| LAPS | Patent lapsed |